Cell line name |
HT-29/5-FU/S |
Accession |
CVCL_0T66 |
Resource Identification Initiative |
To cite this cell line use: HT-29/5-FU/S (RRID:CVCL_0T66) |
Comments |
Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU). Derived from site: In situ; Colon; UBERON=UBERON_0001155. |
Sequence variations |
- Mutation; HGNC; 583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
|
Disease |
Colon adenocarcinoma (NCIt: C4349) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0320 (HT-29) |
Sex of cell |
Female |
Age at sampling |
44Y |
Category |
Cancer cell line |
Publications | PubMed=9600127; DOI=10.1111/j.1349-7006.1998.tb00565.x; PMCID=PMC5921808 Inaba M., Tanaka T., Sawada H. Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure. Jpn. J. Cancer Res. 89:323-327(1998) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_0T66
|
Encyclopedic resources |
Wikidata; Q54896522
|
Entry history |
Entry creation | 08-Jul-2015 |
Last entry update | 05-Oct-2023 |
Version number | 18 |
---|